| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |